Conferences & events

Come & meet our amazing team

Genoskin at the EMBRN 12th International Conference

Advancing immunology and inflammatory skin research with human mast cells

We are excited to participate in the 12th International Conference of the European Mast Cell and Basophil Research Network (EMBRN), taking place from June 10–12, 2026, at the Van Swieten Saal, Medical University of Vienna, in Vienna, Austria.

As a leading international network dedicated to mast cell and basophil biology, EMBRN brings together researchers from academia, clinical science, and industry to share the latest advances in the understanding of mast cells, basophils, eosinophils, and related inflammatory mechanisms in health and disease.

This year, Genoskin will highlight how our human mast cells can help generate physiologically relevant data to better understand mast cell activation, inflammatory responses, and immune-mediated skin mechanisms.

Our poster presentation at EMBRN 2026

Advancing mast cell research with a standardized human primary cell platform

Chenyan Wu1, Cyprien Pecalvel1, Anthony David1, Nicolas Gaudenzio1,5
1Genoskin SAS, Toulouse, France – 2Toulouse Institute of Infectious and Inflammatory Diseases (INFINITy), INSERM UMR1291, CNRS UMR5051, University of Toulouse, Toulouse, France

Understanding mast cell activation in a human-relevant context

Mast cells play a central role in immune regulation, inflammation and allergic responses, making them highly relevant for immunology and safety research. Understanding their activation and mediator release is essential to characterize inflammatory pathways and evaluate the biological effects of new compounds, formulations, and therapeutic candidates.

Our human-relevant in vitro mast cells provide a controlled and reproducible approach to studying mast cell biology, degranulation, and mediator release. By generating mechanistic data in a human context, these immune cells support both academic and pharmaceutical research, from fundamental immunology to drug candidate evaluation, biologics, and safety testing.

Subscribe the newsletter to get the latest updates on upcoming webinars and exclusive scientific insights

Subscribe the newsletter to get the latest updates

& exclusive scientific insights! Delivered to your inbox just once a month.

Comments are closed.